Document is current
Any future updates will be listed below
-
Authors
Sue-Chue-Lam, Colin
Brezden-Masley, Christine
Sutradhar, Rinku
Yu, Amy Ying Xin
Baxter, Nancy Noel
-
Funding
Funding for this research was provided by:
Physicians’ Services Incorporated Foundation
Canadian Institutes of Health Research (148470)
- License Information
-
More Information
Article History
Received: 24 February 2023
Accepted: 24 June 2024
First Online: 22 July 2024
Declarations
:
: All methods were carried out in accordance with relevant guidelines and regulations. The Research Ethics Board at St. Michael’s Hospital (#20–256) and the Office of Research Ethics at the University of Toronto (#40355) waived the requirement for informed consent and provided approval for the present study.
: Not Applicable (NA).
: Dr. Brezden-Masley received grants from Novartis, Eli Lilly, Pfizer, and Astra Zeneca; consultancy fees from Hoffman-La Roche, Novartis, Eli Lilly, Amgen, Pfizer, Taiho, Gilead Sciences, Beigene, Astellas, Astra Zeneca and Seagen; speaker fees from: Novartis, Eli Lilly, Amgen, Pfizer, Gilead Sciences, Astellas, Astra Zeneca and Seagen. All other authors have no competing interests.
